Pep Talk January 2024
Welcome to our first newsletter of the year, where we will be highlighting new additions to our portfolio, resources to help your research, our latest promotional offer and upcoming event.
Welcome to our first newsletter of the year, where we will be highlighting new additions to our portfolio, resources to help your research, our latest promotional offer and upcoming event.
Organoids are exciting models that are rapidly becoming a hopeful platform for many medical advances such as drug screening and disease modeling. However, due to a lack of vascularization, they have limitations for future applications. This review blog summarizes several practical methods for successful organoid vascularization to date.
This edition highlights some of our latest resources and products. These include our high-purity mouse/rat Noggin, our newly launched Flt3L (Qk087) to our growing hematopoietic stem cell range and our latest blog on liver organoids emerging as a transformative model for malaria drug discovery.
Cultivated meat is a nascent industry with a developing regulatory framework, with distinct regional differences. There are however some shared themes across regulatory frameworks and best practice. Within the UK and EU, cultivated meat is considered a novel food and as such falls under the scope of Regulation (EU) No. 2015/2283. In response to this classification, the Food Safety Agency commissioned an internal report into the potential hazards to the consumer associated with the production and consumption of cultured meat. Following a literature review of 154 papers discussing cultured meat as a technology, themes that apply to growth factors have been highlighted and discussed.
Complex 3D liver models that more closely mimic human biology open opportunities for improved drug and vaccine discovery for malaria and related parasitic diseases.
This edition highlights some of our latest resources and products. These include a case study comparing mTESR, Stem Flex and media containing Qkine thermostable FGF2-G3 (Qk053), our high purity CNTF, and newly launched GM-CSF (Qk076) to our growing hematopoietic stem cell range. We are also excited to announce a new distribution agreement in the US with Thomas Scientific and a 30% discount for new customers for three months.
As part of our commitment to constantly improving growth factor quality and availability, we will introduce a modest price increase on January 1st 2024.
Qkine has appointed Thomas Scientific as a new US Distribution Partner, making it easier for stem cell scientists in the US to purchase the entire Qkine product portfolio.
To support customers working on neural stem cells and glial cells, we have launched CNTF which is animal-free and highly bioactive for improved reproducibility in neural stem cell cultures. We have linked some useful resources, including a new neural on-demand webinar on ‘Advancements in Neurobiology Modeling’. Finally, learn about the first of our on-site stocking partnerships which allow customers same-day access to our products to provide the best and fastest service possible.
Watch or listen to Catherine discuss the company’s innovations for the market, and the wider challenges for the sector on the latest episode of The Future of Protein Production podcast.